Arthritis & Rheumatology

• 

  Publication Venue For

  • American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.  73. 2021
  • CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues..  69:1111-1121. 2017
  • Editorial: Shifting the Goal Posts: Treatment Recommendations for Ankylosing Spondylitis and the Newly Defined Condition of Nonradiographic Axial Spondyloarthritis..  68:265-269. 2016
  • A Fellow Led Quality Improvement Project for Improving Contraceptive Compliance in Women Receiving Teratogenic Medications.  67. 2015
  • Antibodies to Histocompatibility Antigens in Juvenile Systemic Lupus Erythematosus Patients.  67. 2015
  • Current Provider Practices and Perceived Barriers for Mental Health Care of Adolescents with SLE.  67. 2015
  • Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia.  67. 2015
  • Gene Expression Profiling Reflects Increased Expression of Coronary Artery Disease Associated Genes in a Case-Control Matched Study of Patient with Rheumatoid Arthritis.  67. 2015
  • A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials.  66:S578-S578. 2014
  • A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence..  66:S509-S509. 2014
  • Assessing Rheumatology Fellows' Teaching Skills Using the Objective Structured Teaching Exercise (OSTE)..  66:S1261-S1261. 2014
  • Care of Women with Rheumatological Conditions during Family Planning and Pregnancy..  66:S598-S598. 2014
  • Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Pregnancies: Disease Activity, Treatment, and Outcomes..  66:S706-S707. 2014
  • Elevated Peripheral Blood Leukocyte Inflammatory Gene Expression in Radiographic Progressors with Symptomatic Knee Osteoarthritis: NYU and OAI Cohorts..  66:S34-S34. 2014
  • Genome-Wide Association Study for Severe Radiographic Knee Osteoarthritis.  66:S435-S436. 2014
  • Hydroxychloroquine Dosing and Disease Activity in a Large Multi-Racial Lupus Cohort.  66:S296-S297. 2014
  • Improving Resident Confidence with the Musculoskeletal Exam through a Rheumatology-Dedicated Musculoskeletal Workshop..  66:S871-S871. 2014
  • Is There an Association Between Persistently High Positive Antiphospholipid Antibody Profile and Organ Damage Accrual in Lupus Patients?.  66:S1-S2. 2014
  • Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from Safety Surveillance..  66:S621-S622. 2014
  • Preliminary Assessment of Predictive Validity of Cartilage Thickness MRI Biomarkers in Knee OA - the Fnih OA Biomarkers Consortium..  66:S87-S88. 2014
  • Randomized Clinical Trial of Group Vs. Individual Physical Therapy for Knee Osteoarthritis..  66:S394-S394. 2014
  • Randomized Clinical Trial of a Patient and Provider Intervention for Managing Osteoarthritis in Veterans.  66:S435-S435. 2014
  • Systemic Lupus Erythematosus and Lactation: Factors Affecting Infant Feeding Choices in Women with SLE..  66:S1168-S1168. 2014
  • The Biosimilar Landscape: A Systematic Review of Its Current Status..  66:S662-S662. 2014
  • Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth 2022
  • Educational Experience and Engagement in the First Two Years of RheumMadness, an Online Community of Inquiry 2022
  • Facilitators of Immunosuppressive Medication Adherence in Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers and Clinic Staff 2022
  • Implementability of a SLE Medication Adherence Intervention 2022
  • Lack of Racial and Ethnic Diversity in Clinical Trials of Psoriatic Arthritis 2022
  • Pilot Study to Implement the Type 1 & 2 SLE Model in an Academic Rheumatology Clinic 2022
  • Racial Differences in Medication Beliefs and Barriers to Taking Medications Among Patients with SLE 2022
  • RheumMadness: Early Learner Experience and Impact 2022
  • Scouting Reports as a Social Constructivist Teaching Tool in RheumMadness 2022
  • Telemedicine's Impact on Radiologic Ordering in an Academic Rheumatology Practice During the COVID-19 Pandemic 2022
  • The Impact of Pregnancy Planning and Medical Readiness on Reproductive Outcomes in Women with SLE 2022
  • The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE 2022
  • A Pregnancy Planning Quality Score to Assess a Systematic Intervention to Improve Pregnancy Planning for Women with SLE 2021
  • Association of HCQ Blood Levels with Type 1 and 2 SLE Activity 2021
  • Association of Limited Health Literacy with Patient-Provider Communication in Systemic Lupus Erythematosus 2021
  • Association of Numeracy with Medication Non-Adherence in Systemic Lupus Erythematosus 2021
  • Baseline Characteristics and Patient Reported Outcomes from a Juvenile Dermatomyositis Registry Inception Cohort 2021
  • CD8 Positron Emission Tomography (PET/CT) Imaging with 89Zr-Df-IAB22M2C in Patients with Inclusion Body Myositis 2021
  • COVID-19 Pandemic-Related Changes in Health Routines and Self-Reported Physical Functioning Among Systemic Lupus Erythematosus Patients 2021
  • COVID-19 Vaccine Hesitancy in Rheumatology Patients 2021
  • Cell-bound Complement Activation Products (CB-CAPs) Predicts Type 1 SLE Activity 2021
  • Concern About the COVID-19 Pandemic and Community Mobility Among Systemic Lupus Erythematosus Patients 2021
  • Depletion of KLRG1+T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM) 2021
  • Intervention to Improve SLE Medication Adherence 2021
  • Long-Term Follow-up of Juvenile Localized Scleroderma Patients Treated with Methotrexate-Based Standardized Regimens (Consensus Treatment Plans) 2021
  • Patient Perspectives on Two Distinct Patterns of Type 2 SLE Symptoms 2021
  • Racial Differences in Medication Beliefs Among SLE Patients 2021
  • The Impact of Health Literacy and Numeracy on COVID-19 Vaccine Hesitancy in SLE 2021
  • Validation of a Self-reported Measure of Extent and Reasons for Nonadherence in SLE 2021
  • Assessment of Lupus Knowledge Through Creation of the Lupus Knowledge Assessment Test (LKAT) 2020
  • Association of Health Literacy and Numeracy with Patient Reported Psychological Outcomes 2020
  • Estimation of Clinically Important Differences in Patient-Reported Outcomes Measurement Information System (PROMIS) Measures in Juvenile Myositis 2020
  • Feasibility and Pilot Study of Mental Health Screening in Juvenile Myositis 2020
  • High-Intensity Interval Training Increases Rheumatoid Arthritis Cardiorespiratory Fitness in Association with Improvements in CD4+T Cell and Skeletal Muscle Mitochondrial Metabolism 2020
  • Intervention to Improve SLE Medication Adherence Using Surescripts Pharmacy Refill Data 2020
  • Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Those with Sacroiliitis 2020
  • Lupus Nephritis Is Associated with a Reduced Prevalence of Fibromyalgia 2020
  • Medication Adherence Barriers and Opportunities to Overcome Them Among Patients with SLE 2020
  • Patient Perspective of Helpfulness of Lupus Medications: A Qualitative Study of Medication Use Within the Type 1 and 2 SLE Model 2020
  • Patient Perspective of the Type 1 and 2 SLE Model: A Qualitative Study 2020
  • Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry 2020
  • Primary Non-adherence in Patients with Systemic Lupus Erythematosus 2020
  • The Frequency of Contraception Documentation in Women with Lupus and Rheumatoid Arthritis Within the RISE Registry 2020
  • The Impact of the COVID-19 Pandemic on the Fibromyalgia Symptoms of SLE Patients 2020
  • Type 2 SLE Symptoms Persist Despite Type 2 Medication Polypharmacy 2020
  • Use of a Patient-reported Survey to Document Contraceptive Use and Interest in Pregnancy to Identify Patients with Unmet Pregnancy Prevention and Planning Needs 2020
  • Using Patient-Reported Outcomes Measures to Classify Patients with Systemic Lupus Erythematous 2020
  • Using a Patient-Engaged Approach to Identify Cross-Cutting Disease Factors Impacting Mental Health in Youth with Rheumatologic Disease 2020
  • Using a Patient-Engaged Approach to Identify Cross-Cutting Disease Factors Impacting Mental Health in Youth with Rheumatologic Disease 2020
  • Barriers and Facilitators of Medication Adherence Among Minority SLE Patients: A Qualitative Study 2019
  • Baseline Clinical and Serological Findings in Pediatric-Onset Discoid Lupus Erythematosus: Analysis of a Multicenter Retrospective Cohort Study 2019
  • Biologic Differences Between Type 1 and 2 Lupus 2019
  • Comparison of PROMIS Computerized Adaptive Testing-Administered Item Banks versus Fixed Short Forms in Juvenile Myositis 2019
  • Disability Among Subtypes of SLE 2019
  • Hospital Admissions and Mortality in Patients with ANCA-associated Vasculitis 2019
  • Investigating Health Literacy and Numeracy in an Academic Center Lupus Cohort 2019
  • Longitudinal Changes in Manifestations of SLE 2019
  • Optimal Hydroxychloroquine Drug Levels in Pregnant Women with Systemic Lupus Erythematosus 2019
  • Otoferlin Is Increased in Muscle and PBMCs from Untreated Children with Juvenile Dermatomyositis: Possible Association with Decreased Circulating Natural Killer Cells 2019
  • Parent Perspectives on Addressing Emotional Health for Youth with Juvenile Myositis: A Qualitative Focus Group Study 2019
  • Pharmacotherapies Targeting Type 2 SLE Symptoms 2019
  • Predictors of Health Care Transition Practices Among North American Pediatric Rheumatology Providers 2019
  • Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project 2019
  • Profiling of Gene Expression, Immune Cell Subtypes, and Circulating Protein Biomarkers in Systemic Lupus Erythematosus Patients Treated with the Selective Immunoproteasome Inhibitor, KZR-616 2019
  • Racial Disparities in Factors Associated with SLICC Damage Score Among Patients with SLE 2019
  • Racial Disparities in Lupus Medication Adherence 2019
  • Safety, Pharmacokinetics, and Pharmacodynamics of a Lyophilized Drug Product of KZR-616, a Selective Inhibitor of the Immunoproteasome 2019
  • The PROMIS-29 as a Measure of Type 1 and 2 SLE Activity 2019
  • Transitions in Lumbar Spine Osteoarthritis: The Johnston County Osteoarthritis Project 2019
  • Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial 2019
  • A Quality Improvement Project to Increase Documentation Efficiency in an Academic Rheumatology Practice 2019
  • High Intensity Interval Training Improves Rheumatoid Arthritis Cardiorespiratory Fitness and Systemic Inflammation in Association with Alterations in Skeletal Muscle Metabolomic Profiles 2019
  • Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Those with Sacroiliitis 2019
  • Patterns of Etanercept Use in the Childhood Arthritis and Rheumatology Research Alliance Juvenile Idiopathic Arthritis Registry 2019
  • A Comparison of RADAI5 and RAPID3 Disease Measures 2018
  • Association of Knee Ligament and/or Meniscal Injury with Radiographic Knee Osteoarthritis in Military Officers 2018
  • Baseline Features and Outcomes of Pediatric-Onset Discoid Lupus Erythematosus: Interim Data Analysis of a Multicenter Retrospective Cohort Study 2018
  • Births to Women with Systemic Lupus Erythematosus Can be Identified Accurately in the Electronic Health Record 2018
  • Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis 2018
  • Disease Activity and Its Measurement in Patients with RA across the US: Data from the Rheumatology Informatics System for Effectiveness (RISE) Registry 2018
  • Evaluating Gaps in Reproductive Health Knowledge Among Women with Rheumatic Diseases 2018
  • Explaining the Discrepancy between Physician and Patient-Reported Measures of Disease Activity in Systemic Lupus Erythematosus 2018
  • Global Consensus Building and Prioritization of Major Challenges in Lupus Diagnosis, Care, Treatment and Research 2018
  • Increased Adverse Childhood Experiences in Children with Arthritis: An Analysis of the National Survey of Children's Health 2018
  • Lymphocyte Immunophenotypes at Randomization on the Scleroderma: Cyclophosphamide or Transplantation Trial: Comparison of Treatment Naive and DMARD Treated Participants with Healthy Controls 2018
  • Patients with Childhood-Onset SLE (cSLE) and Hypertension Have Consistently Higher Serum Concentrations of C3 and C4 Than Those without Hypertension 2018
  • Pharmacokinetics of Cyclophosphamide in Scleroderma Treated By Cyclophosphamide Versus Transplantation 2018
  • Physical Function Trajectories in Children with Juvenile Myositis 2018
  • Plasma Mir-146a-5p Associates with Beneficial Body Composition and Plasma Metabolic Profiles in Rheumatoid Arthritis 2018
  • Practice Variation in Prescriptions of Non-TNFi Biologics and Tofacitinib: Data from the Rheumatology Informatics System for Effectiveness (RISE) Registry 2018
  • Pregnancy Outcomes Among Women with Rare Autoimmune Diseases 2018
  • Pregnancy Outcomes in Patients with Interstitial Lung Disease Related to Autoimmune Disease and Sarcoidosis 2018
  • Pregnancy Outcomes in Undifferentiated Connective Tissue Disease- a Single Academic Center's Experience 2018
  • Pro-Inflammatory High Density Lipoprotein Function Is Associated with Accelerated Carotid Intimal Medial Thickness Progression in Childhood-Onset SLE 2018
  • Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies 2018
  • Shared Genetic Origins Among Anti-Proteinase 3 and Anti-Glomerular Basement Membrane Double-Positive Human Autoantibodies 2018
  • Standing Balance and Walking Time Among Older Adults with and without Joint Hypermobility: The Johnston County Osteoarthritis Project 2018
  • The 66/68 Joint Count for the Measurement of MSK Disease Activity/Peripheral Joint Activity in Psa: A Grappa-Omeract Working Group Initiative 2018
  • The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Updated Report of Baseline Patient Characteristics and Treatment Choices 2018
  • The Influence of Depression on Clinical Features of Systemic Lupus Erythematosus 2018
  • The Relationship of Pain, Fatigue and Emotional Distress with Quality of Life in Juvenile Myositis 2018
  • The Use of Patient-Reported Outcome Measures to Assess Clinical Features of Fibromyalgia in SLE 2018
  • A Quality Improvement Initiative to Increase Adherence to Hydroxychloroquine Dosing Guidelines at an Academic Medical Center 2018
  • Analyze Myositis with Ultrasound and Exercise (AMUSE) Kids- Initial Analysis of Longitudinal Data 2018
  • Stepping It up: The Use of Physical Activity Monitors As an Outcome Measure in Juvenile Myositis 2018
  • Answering Reproductive Health Questions That Your Patients Want to Know: Impediments to Family Building and Risks of Contraception 2017
  • Biomarkers Predictive of Pain Improvement in Knee Osteoarthritis Subjects Treated with the Anti-IL-1 alpha/beta Dual Variable Domain Immunoglobulin ABT-981 2017
  • Cardiovascular and Cerebrovascular Comorbidities of Juvenile Dermatomyositis in United States Children 2017
  • Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database 2017
  • Easily Obtainable Myositis Autoantibody Panel Predictive Factors 2017
  • Effects of a Home-Based Telephone-Supported Physical Activity Program on Physical Function Among Older Adults with Chronic Low Back Pain 2017
  • Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes 2017
  • Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data 2017
  • Initial Validation of Patient-Reported Outcomes Measurement Information System (PROMIS (R)) in Children with Juvenile Myositis 2017
  • Longitudinal Predictors of Physical Function in Juvenile Myositis 2017
  • Physical therapy vs. internet-based exercise training for patients with knee osteoarthritis: Results of a randomized controlled trial. 2017
  • Plasma CXCL4 As a Biomarker in Juvenile Systemic Sclerosis 2017
  • Quantiferon Testing in a Clinical Trial of Systemic Lupus Erythematosus 2017
  • Rheumatoid Arthritis and the Risk for Interstitial Lung Disease: A Comparison of Risk Associated with Biologic and Conventional Dmards 2017
  • Serum Galectin-3 in Rheumatoid Arthritis Compared with Healthy Controls and Subjects with Prediabetes before and after High-Intensity Interval Training 2017
  • Skeletal Muscle Cytokine and Myostatin Responses to High-Intensity Interval Training in Rheumatoid Arthritis Contrasted with Prediabetes Mellitus 2017
  • The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Interim Report of Baseline Patient Characteristics and Treatment Choices 2017
  • The Interaction between Genetic Risk Factors and Age of Disease Onset in Juvenile Dermatomyositis 2017
  • The Localized Scleroderma Quality of Life Instrument (LoSQI): Initial Validation in Pediatric Localized Scleroderma 2017
  • Tissue-Engineered Human Skeletal Muscle Model of Rheumatoid Arthritis 2017
  • Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation 2017
  • Updating the Knee Osteoarthritis Intra-Articular Corticosteroid Meta-Analysis with Two Large Trials of Extended-Release Triamcinolone Acetonide (FX006) Versus Placebo 2017
  • Baseline characteristics of the first 123 patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA comparative effectiveness study 2017
  • Corticosteroid Regimen Use in the Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis 2017
  • Methotrexate use and route of administration in JIA: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry 2017
  • Underutilization of Social Workers for Mental Health Care of Adolescents in Pediatric Rheumatology: A Mixed Methods Study 2017
  • How Well Do Rheumatology Fellows Manage Acute Infusion Reactions? a Pilot Curricular Intervention 2017
  • A Non-Linear Relationship Between Physical Activity and Serum Uric Acid Concentrations: Nhanes 2003-2004 2016
  • A Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis 2016
  • Assessment of Comparative Immunogenicity in Biosimilar Development: Immunogenicity and Pharmacokinetics Following a Single Dose of M923, a Proposed Biosimilar for Reference Adalimumab (HUMIRA (R)), Compared with US- and EU-Sourced Reference Adalimumab in Healthy Subjects 2016
  • Association of Anterior Cruciate Ligament/Meniscal Injury with Knee Function, Knee Pain, and Knee Osteoarthritis in Military Officers 2016
  • Associations Between 25-Hydroxyvitamin D, Parathyroid Hormone, and Cathelicidin Concentrations with Inflammation and Cardiovascular Risk in Subjects with Pediatric Systemic Lupus Erythematosus 2016
  • Attitudes Toward Patient-Reported Outcome Instruments for the Assessment of Raynaud's Phenomenon in Systemic Sclerosis 2016
  • Causes of Cesarean Section and Labor Induction in Systemic Lupus Erythematosus and Rheumatoid Arthritis Pregnancies 2016
  • Contraceptive Methods in Women with Rheumatoid Arthritis 2016
  • Does Physical Activity Change after Total Hip or Knee Arthroplasty: A Systematic Review and Meta-Analysis 2016
  • Environmental Scan of Rheumatoid Arthritis Patient Registries Around the World: An Omeract Initiative 2016
  • Establishing Quality of Life Content Domains in Pediatric Localized Scleroderma 2016
  • Feasibility of Same Day Adipose Tissue Harvest, Cell Processing and Subcutaneous Delivery of Adipose Derived Regenerative Cells into Fingers of Scleroderma Patients within a Randomized Double Blind Clinical Trial 2016
  • Genetic Polymorphism of IL-1RN Encoding the IL-1 Receptor Antagonist Predicts Radiographic Severity of Symptomatic Knee OA 2016
  • Infertility in Women with Rheumatoid Arthritis 2016
  • Is Joint Hypermobility Related to Foot Osteoarthritis and Symptoms? 2016
  • Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study 2016
  • Multicenter Prospective Study on the Role of Urinary HER2 As a Lupus Nephritis Biomarker 2016
  • Patterns of Medication Use in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis & Rheumatology Research Alliance Registry 2016
  • Practice-Based Differences Between Pediatric Rheumatologists and Dermatologists Caring for Children with Discoid Lupus 2016
  • Practice-Level Variation in Quality of Care in the Acr's Rheumatology Informatics System for Effectiveness (RISE) Registry 2016
  • Predictors of Changes in Disease Activity Among Children with Juvenile Dermatomyositis 2016
  • Randomized Clinical Trials of Systemic Lupus Erythematosus: Evaluating Differences in the Enrolled Populations 2016
  • SLE and Uctd in the Rheumatology Informatics System for Effectiveness (RISE) Registry 2016
  • Sustained Improvement in Documentation of Disease Activity Measurement As a Quality Improvement Project at an Academic Rheumatology Clinic 2016
  • The Frequency of and Patient Characteristics Associated with Fear of Movement in Adults with Symptomatic Knee Osteoarthritis 2016
  • Early Onset Morbidity and Mortality in Female Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis and Interstitial Lung Disease 2016
  • Evaluating Transfer of Certolizumab Pegol into Breast Milk: Results from a Prospective, Postmarketing, Multicenter Pharmacokinetic Study 2016
  • International Patient and Physician Consensus on Psoriatic Arthritis Outcomes for Clinical Trials 2016
  • Patient and Parent Global Assessments of Disease Impact in Pediatric Localized Scleroderma: Correlates of Patient Reported Health-Related Quality of Life and Parent Reported Family Impact Domains 2016
  • Perceived Stress and Reported Cognitive Symptoms Among Patients with Systemic Lupus Erythematosus 2016
  • A Comparison of Pregnancy Outcomes before and after Lupus Diagnosis 2015
  • A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE) 2015
  • Adalimumab in Patients with Active, Noninfectious Uveitis Using High-Dose Corticosteroids 2015
  • Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic 2015
  • Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials 2015
  • Gender Differences in Pediatric Localized Scleroderma: Clinical and Patient-Reported Outcomes 2015
  • Improving the Medication Prior Authorization Process in a University Based Rheumatology Practice 2015
  • Interaction Between Senescent T Cells and Fibrocyte-like Cells through CD31, TNF alpha, and IL-17 Create a Tissue Destructive Environment in the Synovium in Juvenile Idiopathic Arthritis 2015
  • Predictors of Longitudinal Quality of Life Impact in Pediatric Localized Scleroderma 2015
  • Prospective, Standardized, Longitudinal Assessment Reveals Higher Prevalence of Extracutaneous Manifestations in a Pediatric Localized Scleroderma Cohort 2015
  • Racial Disparities in Lupus Pregnancy 2015
  • Relationship of Race, Ethnicity, and Outcomes in Pediatric Localized Scleroderma: Possible Differences in Disease Activity 2015
  • Treatment and Outcomes in Pediatric SLE Patients in South Africa 2015
  • Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases 2015
  • Increased Morbidity and Mortality in Female Versus Male Tumor Necrosis Factor-Transgenic Mice 2015
  • Tumor Necrosis Factor-a (TNF-a) and Interferon Gamma Inducible Protein-10 (IP-10) As Predictors of Active Disease Status in Localized Scleroderma 2015
  • Pulse- Pediatric Update on Lupus in South Africa: Epidemiology and Management. 2014
  • The Relationship Between Disease Activity and Levels of HMGB1 in Patients with Rheumatoid Arthritis 2014
  • Circulating T-Helper Cell-Associated Cytokines and Chemokines in Localized Scleroderma. 2014
  • Predictors of Disease Relapse in Juvenile Localized Scleroderma 2014